GHDx
Published on GHDx (https://ghdx.healthdata.org)


Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study

General Info

Geography 
Australia (AUS)
France (FRA)
Germany (DEU)
Japan (JPN)
Netherlands (NLD)
Spain (ESP)
United Kingdom (GBR)
United States of America (USA)
View all
Coverage type 
Country
Time period covered 
January, 2017 - December, 2019
Data type
Scientific literature
Keywords 
Guillain-Barre syndrome, Ischemic heart disease

Citation

Authors 
Li X, Ostropolets A, Makadia R, Shoaibi A, Rao G, Sena AG, Martinez-Hernandez E, Delmestri A, Verhamme K, Rijnbeek PR, Duarte-Salles T, Suchard MA, Ryan PB, Hripcsak G, Prieto-Alhambra D
Journal 
BMJ
Pages 
n1435
Publication year 
2021
Suggested citation 
Li X, Ostropolets A, Makadia R, Shoaibi A, Rao G, Sena AG, Martinez-Hernandez E, Delmestri A, Verhamme K, Rijnbeek PR, Duarte-Salles T, Suchard MA, Ryan PB, Hripcsak G, Prieto-Alhambra D. Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study. BMJ. 2021; 373: n1435.

Source URL:https://ghdx.healthdata.org/record/characterising-background-incidence-rates-adverse-events-special-interest-covid-19-vaccines